The semi-automated device uses new-generation TRPS technology, enabling the measurement of complex nanoparticle size, concentration, and charge—with unparalleled precision and accuracy
New end-to-end compliant-ready workflow helps biotherapeutic protein manufacturers meet regulatory and attribute-based product analysis requirements for drug identity, purity, and quality